AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Terumo Corporation
Video analysis: TRUMY
All videosNo video analysis for this stock yet. Request one from our team.
News: TRUMY
Terumo Corp. (OTCMKTS:TRUMY) Short Interest Down 46.0% in July
Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) was the recipient of a large decrease in short interest in the month of July. As of July 31st, there was short interest totaling 46,134 shares, a decrease of 46.0% from the July 15th total of 85,412 shares. Currently, 0.0% of the company's stock are short sold. Based
Terumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks Transcript
Terumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks Transcript
Terumo (OTCMKTS:TRUMY) Shares Gap Up on Strong Earnings
Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) gapped up prior to trading on Monday after the company announced better than expected quarterly earnings. The stock had previously closed at $14.54, but opened at $16.14. Terumo shares last traded at $16.19, with a volume of 4,271 shares trading hands. The company reported $0.30 earnings per share
Lantheus (NASDAQ:LNTH) versus Terumo (OTCMKTS:TRUMY) Critical Review
Terumo (OTCMKTS:TRUMY - Get Free Report) and Lantheus (NASDAQ: LNTH - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation. Profitability This table compares Terumo and Lantheus' net margins, return
4 Medical Products Stocks Poised to Win Despite Industry Headwinds
Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation, pricing and execution as healthcare demand stays resilient.
